Little is known about the role of the immune system in the earliest stages of breast carcinogenesis. We studied quantitative differences in immune cell types in normal and benign biopsy breast tissues and evaluated associations with breast cancer risk. We found that lobules in benign breast disease tissues have quantitatively higher densities of multiple immune cell types compared to normal breast tissues, especially dendritic cells and macrophages. Among women with benign breast disease, a lack of B cells was associated with increased breast cancer risk. These results provide a necessary initial characterization of basic immune cell components within breast tissues in normal and abnormal benign states and identify promising lines for further investigation, particularly the role of macrophages and B cells in inhibiting or promoting breast cancer from the premalignant state. 
Statement of Translational Relevance
Little is known about the role of the immune system in the earliest stages of breast carcinogenesis. We studied quantitative differences in immune cell types in normal and benign biopsy breast tissues and evaluated associations with breast cancer risk. We found that lobules in benign breast disease tissues have quantitatively higher densities of multiple immune cell types compared to normal breast tissues, especially dendritic cells and macrophages. Among women with benign breast disease, a lack of B cells was associated with increased breast cancer risk. These results provide a necessary initial characterization of basic immune cell components within breast tissues in normal and abnormal benign states and identify promising lines for further investigation, particularly the role of macrophages and B cells in inhibiting or promoting breast cancer from the premalignant state.
Introduction
Benign breast disease (BBD) refers to a variety of benign pathologic findings in the breast. These can include abnormalities of both the epithelium and the supporting stroma. As a group, women with BBD are at an increased risk of breast cancer compared to the general population, with the degree of risk stratified based on the degree of epithelial proliferation (1, 2) . In addition to the glandular epithelial cells and underlying stroma that enable lactation, the normal mammary gland contains a mucosal immune system (3) . making it similar to other mucosal organs, such as the gastrointestinal tract and the lung. Integration of the immune system into the mammary gland is essential for multiple reasons, including provision of secretory immunoglobulin A (IgA) for neonatal protection, protection of the gland from microbial infection, and maintenance of normal glandular structure and function (4) (5) (6) (7) (8) (9) . The observations that immunodeficient mice develop breast adenomas and cancers more frequently than their immunocompetent counterparts suggests that the immune system plays a critical role in protection from malignancy (10) . In contrast, deregulation of the mucosal immune system may promote subclinical tumor-promoting chronic inflammation similar to other mucosal environments (11) . While the role of the immune system in breast cancer progression has been actively studied, its role in breast carcinogenesis is much less studied despite its potential for impacting cancer prevention.
Our objective for this project was to examine patterns of immune cell infiltration in normal and BBD breast tissues and to investigate associations with breast cancer risk. With ~1 million women undergoing a breast biopsy with benign findings in the United States every year, an immune profile of risk could help to improve risk stratification, identify pathologic immune effectors, and inform novel immune-related breast cancer prevention strategies.
Methods

Study design and breast tissue samples
Institutional Review Board approval was obtained prior to conducting this research. We planned a case-control study to perform histologic quantification of immune cell infiltrates in breast tissues from two tissue sources. Normal breast tissues were obtained from the Susan G. Komen® for the Cure Tissue Bank at IU Simon Cancer Center (i.e. Komen Tissue Bank = KTB), and breast tissues with benign disease were obtained from the Mayo BBD Cohort. The normal breast tissue samples from the KTB are a unique resource of tissue from donor women with no known clinical breast abnormalities.
Prior histologic review of a large sample of these tissues confirms that the majority indeed have no histologic abnormalities (12) .
The Mayo BBD Cohort is a unique cohort of approximately 15,000 women who had a benign breast biopsy at Mayo Clinic from 1967-2001. Cohort resources include data on risk factors, later breast cancer events, and archived benign biopsy tissues. Women who developed breast cancer subsequent to their benign biopsy are defined as cases, with controls defined as women with similar length of follow-up who did not develop breast cancer. Within the Mayo BBD Cohort, a nested set of 100 cases and 100 controls were randomly selected from the latter portion of the Mayo BBD cohort (1992-2001) to be nearer the years during which KTB samples were collected, and were matched on age, year at biopsy, and length of follow-up. Once these case-control pairs were established, an age-matched normal breast tissue donor was randomly selected from the KTB samples available as of June 2012 (~2500 total available) for each BBD casecontrol pair to create an age-matched triplet: KTB normal tissue donor, BBD case, and BBD control. Groups were also frequency matched to ensure a similar distribution of first-degree family history of breast cancer across the three groups. Six of the selected BBD case-control pairs involved a subject later excluded from the BBD cohort based on additional data review; two due to history of bilateral prophylactic mastectomy prior to the benign breast biopsy and four due to breast cancer identified at the time of the BBD biopsy. Thus, the final analysis sample excluded the six affected triplets resulting in a set of 94 triplets totaling 282 subjects.
Histology and immune cell quantitation
For each study sample, serial formalin fixed paraffin embedded tissue sections were stained immunohistochemically using previously described methods (13) . Each H&E digital image was assessed by the study breast pathologist (DWV) for an overall histologic impression of the greatest severity of abnormality according to established categories of benign breast lesions: no histologic abnormality, nonproliferative changes, proliferative changes without atypia, or atypical hyperplasia. From each digital H&E image, 10 representative lobules (or all lobules if <10 present) were selected. These same lobules were then identified, circled digitally, and annotated on successive immunostain sections for immune cell quantitation.
Digital images were analyzed using Aperio ImageScope Software, version 12.1.0.5029 (Leica Biosystems®, Buffalo Grove, IL), and quantitative image analysis was performed using methods based on the FDA-approved algorithms optimized as previously described(3). The area of each circled lobule was calculated and digital quantitation was used to enumerate the number of positively staining cells per mm 2 within all selected lobules. For DC quantitation, CD11c was measured as ratio of positive to total pixels due to a more diffuse pattern of particle staining (see Figure 1 ).
Statistical analysis
Cell densities were calculated as the number of positively stained cells per mm 2 of lobule area for all immunostains except CD11c, where the positive:total pixel ratio was multiplied by 100 to express it as a percentage. Multiple lobules measured within each sample were condensed to a single measure per subject by taking the median across lobules within a sample. Immune cell measures were compared between groups using Wilcoxon signed-rank tests for univariate analysis on the matched sets. Multivariable analysis was performed using conditional logistic regression with a stratification variable to account for matched sets. Continuous immune cell measures were transformed using the Van der Waerden transformation prior to fitting statistical models(14). Due to a large proportion of lobules with zero counts for some immune cell types, a secondary analysis categorized each sample according to whether all lobules in the sample had a zero count, some lobules had zero count, or no lobules had a zero count; analysis using this variable was then performed using conditional logistic regression as described above. Analysis was performed using SAS® (SAS® Institute Inc., Version 9.3); graphs were drawn using R software (R Foundation, Vienna, Austria, Version 3.0.2). P-values < 0.05 were considered statistically significant. Because the goal of this exploratory study was to provide the first detailed characterization of multiple immune cells types in pre-malignant breast tissues with differing levels of risk and because pairwise comparisons for the three risk groups were planned a priori, no corrections for multiple comparisons were performed in order to limit the possibility of type II error. However, a modified Bonferroni-corrected alpha-level for three pairwise comparisons would be 0.0167 if applied.
Results
Characteristics of subjects and tissue samples
In the final age-matched study set of 94 triplet samples (N = 282), the mean age was 54 (Table 1) . Among these 282 samples, 2687 lobules were assessed (898 BBD cases, 922 BBD controls, 867 KTB) to characterize the immune cell presence. Among KTB normal tissue donors, histologic characteristics were similar to those of the larger previously assessed sample (12) , with no histologic abnormality in 63.0%, nonproliferative fibrocystic changes in 27.2%, and proliferative findings (± atypia) in 9.8%. Comparing BBD cases and controls, cases had a greater frequency of atypical hyperplasia and less nonproliferative changes, consistent with the higher breast cancer risk associated with these benign lesions(2). Among BBD cases, the subsequent breast cancers were: 26% DCIS, 46% invasive ductal cancer, 10% invasive lobular cancer, 6% invasive mixed ductal/lobular, and 12% other invasive histologies; 75% of invasive cancers were estrogen receptor positive.
Microanatomic patterns of immune cell distribution
Based upon qualitative review of histologic images, we observed characteristic patterns of immune cell distribution (Figure 1, A-E) . The CD4+ positive cells were located both in the intralobular stroma between acini and also interspersed among the epithelial cells ( Figure 1A) . The CD8+ cells were scattered uniformly across lobules, with the majority of CD8+ cells in close association with the basal aspect of the epithelium in most acini of the lobule (Figure 1B) , although occasional CD8+ cells were also observed in the intralobular stroma. The CD11c staining formed a reticular staining pattern, highlighting dendritic cell processes, outlining lobular acini, also primarily and closely associated with the basal aspect of the epithelium ( Figure 1C ). When present, CD20+ cells were more likely to be located in the intralobular stroma rather than in direct association with the epithelium (Figure 1D ). The CD68+ macrophages had a less compartmentalized pattern and were located in acinar epithelium, within acinar lumens, and also within intralobular stroma ( Figure 1E ).
Relative frequencies of immune cell types are consistent across tissue groups
Boxplots comparing densities of the various immune cell types across the three tissue groups demonstrate a similar relative frequency of the five immune cell types within each group (Figure 2, Supplemental Table 1 ). In all three groups, CD68+ macrophages were most frequent, followed by CD8+, CD4+, and CD20+ lymphocytes, respectively (CD11c is not directly comparable to these other cell types due to the percent-positive pixel measure). Compared to KTB normal samples, BBD samples (both cases and controls) showed generally higher densities of all immune cell types, but there was substantial variability within each group.
BBD samples have increased macrophages and dendritic cells relative to KTB
Differences in immune cell densities between sample groups were evaluated by calculating pairwise differences of the median values between age-matched samples of different groups (KTB, BBD cases, BBD controls). In unadjusted analysis, BBD cases and controls had elevated levels of all immune cell types compared to KTB normal tissues with the exception of the CD4+ cell density comparison between BBD cases and KTB samples, which was not statistically significant. The largest effects were seen with CD68+ and CD11c+ cells ( Table 2 and Figure 3 ). CD68+ cell density significantly elevated after adjustment for histologic impression (p = 0.02 for BBD cases and p = 0.005 for BBD controls compared to KTB). Similarly, CD11c+ pixel percent was higher in BBD cases and controls compared to KTB samples and remained significant after adjustment (p = 0.01 and p = 0.006, respectively).
Because we observed that many lobules lacked several immune cell subtypes (most notably CD4+ T cells and CD20+ B cells), we also analyzed findings based on the percentage of samples having all, some, or none of the lobules with a value of zero immune cells ( Table 3) . Similar to analysis of median cell densities, unadjusted analysis of zero densities showed that CD68+, CD4+, CD8+, and CD20+ cells were significantly more prevalent in BBD compared to KTB samples. As virtually all lobules demonstrated presence of CD11c+ pixels regardless of sample group, the analysis of zero counts was not informative for this cell type. After adjustment for histologic impression, only CD68+ macrophages remained significantly different in separate comparisons of KTB with BBD cases and controls.
Absence of B cells is associated with increased risk of subsequent breast cancer development
Comparing median cell densities between BBD cases and controls, BBD cases generally had lower immune cell densities compared to controls but the differences were smaller in magnitude compared to the differences between BBD and KTB samples ( Table 2 and Figure 3) . Notably, median CD68 cell density did not differ between BBD cases and controls. In unadjusted analyses of median cell density, BBD cases showed significantly lower cell densities compared to BBD controls for CD8+ cells (p = 0.009), CD11c+ cells (p = 0.04), and CD20+ cells (p = 0.04). After adjustment for histologic impression, differences remained significant only for CD20+ B cell density (p = 0.02).
Comparing BBD cases with controls using the zero cells approach ( 
Discussion
In this study, we enumerated major immune cell subsets in mammary gland lobules in normal and BBD tissues, and we ) and resulting inflammation that is either pro-or anti-tumorigenic (26) . Further study will be required to identify the polarization state of macrophages in BBD tissue.
Other evidence supports a role for chronic inflammation in breast cancer development. Population-based studies show that long-term use of aspirin and ibuprofen is associated with reduced incidence of breast cancer (27) (28) (29) (30) (31) .
Individuals with higher CRP levels have increased risk of breast cancer (32) , and chronically immunosuppressed solid organ transplant recipients also have reduced numbers of breast cancers (33) . Our observed predominance of macrophage and dendritic cells in BBD tissues suggest chronic inflammatory responses of unknown etiology, possibly in response to persistent irritants, bacteria or viruses (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) . Inflammation has also been recognized as tumor-promoting in multiple other epithelial cancer types, especially of the GI tract where aspirin is associated with reduced risk of colorectal cancer (38) . Similar to our finding of inflammation in BBD tissues with premalignant potential, research on colorectal adenomas has shown that precancerous polyps have higher infiltration of T cells and macrophages compared to non-polypoid lesions (39) . Mechanisms of inflammation-induced carcinogenesis that are supported by current research across multiple tumor types include NF-KB driven production of proinflammatory cytokines in immune cells (which promote neoplastic transformation of epithelial cells), and generation of free radicals with resulting epithelial DNA damage (40) .
Limitations of our findings include the lack of functional data on immune cell types, although our results form the foundation for future studies and are a notable improvement over previously published data in this field. Prior studies on immune cell subsets in non-malignant breast tissue(41-43) involved much smaller sample sizes and lacked information on subsequent cancer risk. Other limitations of our study include 1) only 10 lobules were studied per sample, and 2) quantitation was limited to breast lobules and intralobular stroma; we did not evaluate interlobular stroma. Both factors were related to the time-intensive nature of the cell quantitation and may be overcome in the future by technological advances with multiplexing immunostains on a single tissue section, allowing better assessment of immune cell function via multiple markers. Lastly, the older age of BBD tissues and different tissue processing protocols between BBD and KTB tissues could impact immune cell findings between these two groups. This seems unlikely as immunostains used for major immune cell types are robust, and generally immune cells were more abundant in BBD tissues, suggesting that there was not a lack of antigen retrieval in these older samples. Strengths of our study include a systematic and detailed quantitation of major immune cell subsets in both normal and benign breast disease tissues, which has not been previously reported.
In conclusion, we found that lobules in benign breast disease tissues have quantitatively higher densities of ) was added to the denominator to avoid division by zero. b Adjusted for histologic impression 
